Kyle Carver - 09 Dec 2025 Form 4 Insider Report for Evommune, Inc.

Role
Chief Financial Officer
Signature
/s/ Gregory S. Moss, Attorney-in-Fact
Issuer symbol
EVMN on NYSE
Transactions as of
09 Dec 2025
Net transactions value
-$237,094
Form type
4
Filing time
11 Dec 2025, 16:20:50 UTC
Previous filing
12 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Carver Kyle Chief Financial Officer C/O EVOMMUNE, INC., 1841 PAGE MILL ROAD, SUITE 100, PALO ALTO /s/ Gregory S. Moss, Attorney-in-Fact 11 Dec 2025 0001757072

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EVMN Common Stock Tax liability $237,094 -13,290 -18% $17.84 62,510 09 Dec 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units.